IVA
Price
$4.02
Change
-$0.12 (-2.90%)
Updated
Sep 11 closing price
Capitalization
1.01B
15 days until earnings call
Intraday BUY SELL Signals
SLDB
Price
$8.70
Change
-$0.37 (-4.08%)
Updated
Sep 11 closing price
Capitalization
932.32M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVA vs SLDB

IVA vs SLDB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IVA vs. SLDB commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVA is a Hold and SLDB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVA($1.01B) has a higher market cap than SLDB($932M). SLDB YTD gains are higher at: 54.255 vs. IVA (-13.548).
IVASLDBIVA / SLDB
Capitalization1.01B932M108%
EBITDAN/A-210.48M-
Gain YTD-13.54854.255-25%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A378M-
Total DebtN/A20.2M-
FUNDAMENTALS RATINGS
IVA vs SLDB: Fundamental Ratings
IVA
SLDB
OUTLOOK RATING
1..100
5679
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLDB's Valuation (26) in the Biotechnology industry is in the same range as IVA (44) in the null industry. This means that SLDB’s stock grew similarly to IVA’s over the last 12 months.

SLDB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IVA (100) in the null industry. This means that SLDB’s stock grew similarly to IVA’s over the last 12 months.

SLDB's SMR Rating (98) in the Biotechnology industry is in the same range as IVA (98) in the null industry. This means that SLDB’s stock grew similarly to IVA’s over the last 12 months.

SLDB's Price Growth Rating (38) in the Biotechnology industry is in the same range as IVA (63) in the null industry. This means that SLDB’s stock grew similarly to IVA’s over the last 12 months.

SLDB's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for IVA (100) in the null industry. This means that SLDB’s stock grew significantly faster than IVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVASLDB
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (IVA: $4.02 vs. SLDB: $8.70)
Brand notoriety: IVA and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVA: 210% vs. SLDB: 133%
Market capitalization -- IVA: $1.01B vs. SLDB: $932.32M
IVA [@Biotechnology] is valued at $1.01B. SLDB’s [@Biotechnology] market capitalization is $932.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVA’s FA Score shows that 0 FA rating(s) are green while SLDB’s FA Score has 2 green FA rating(s).

  • IVA’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than IVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVA’s TA Score shows that 5 TA indicator(s) are bullish while SLDB’s TA Score has 5 bullish TA indicator(s).

  • IVA’s TA Score: 5 bullish, 4 bearish.
  • SLDB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IVA is a better buy in the short-term than SLDB.

Price Growth

IVA (@Biotechnology) experienced а -15.90% price change this week, while SLDB (@Biotechnology) price change was -15.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

IVA is expected to report earnings on Sep 27, 2026.

SLDB is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBSTX64.450.67
+1.05%
Neuberger Quality Equity Tr
LMBCX14.47N/A
N/A
Franklin U.S. Small Cap Equity C
MXREX13.89N/A
N/A
Empower Real Estate Index Inv
JSJFX15.92N/A
N/A
JHancock Small Cap Dynamic Growth R6
AEPFX64.63-0.21
-0.32%
American Funds EUPAC F-2

IVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with NKTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-2.90%
NKTX - IVA
38%
Loosely correlated
+3.56%
TVGN - IVA
37%
Loosely correlated
+0.96%
ABEO - IVA
36%
Loosely correlated
-1.19%
CABA - IVA
35%
Loosely correlated
-0.36%
SLDB - IVA
33%
Loosely correlated
-4.08%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-4.08%
EDIT - SLDB
54%
Loosely correlated
+1.89%
FDMT - SLDB
51%
Loosely correlated
-2.37%
IMTX - SLDB
49%
Loosely correlated
+0.46%
RCKT - SLDB
49%
Loosely correlated
-3.74%
CRBU - SLDB
49%
Loosely correlated
-7.30%
More